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Background
Immunotherapy has recently shown promising clinical
activity in multiple tumor types but standard in vitro
immuno-oncology models for preclinical and clinical
predictivity are lacking. Macrophages have been shown
to have both tumor promoting and tumor preventing
properties dependent upon their differentiation state
with M2 macrophages thought to promote tumor
growth via enhanced angiogenesis, metastasis and
immune evasion. 3D tissue models have been shown to
better represent the growth and function of breast
tumors and the incorporation of other cell types, such
as fibroblasts and adipocytes, and perfusion flow has
have been shown by us and others to produce more
relevant drug responses. To continue to improve the
relevancy of our 3D cancer models we have incorpo-
rated macrophages into our current 3D perfusion tri-
culture breast tumor model to form a tetra-culture
model consisting of cancer cells, fibroblasts, adipocytes,
and macrophages.
Materials and methods
Cancer cell lines, including MCF7, were incorporated
into hydrogel/scaffolding combinations along with
human mammary fibroblasts and cultured with separate
3D tissues containing either adipocytes or peripheral
blood mononuclear cells (PBMC) or differentiated M1,
M2 macrophages. These tetra-cultures were grown
under perfusion flow for 7 – 21 days and assayed with
both destructive and non-destructive methods for survi-
val (Live/Dead), proliferation (PrestoBlue, PicoGreen),
morphology (multiphoton microscopy, H&E), marker
expression (IHC, RT-PCR), secreted factors (Luminex),
motility/migration, and macrophage differentiation
states. Additional tests examined drug response changes
in the presence of macrophages. Under IRB approved
protocols, patient specific tumor cells and immune cells
are being incorporated into the 3D tetra-culture models.
Results
The 3D tumor microenvironment impacted the macro-
phages by affecting differentiation and survival, and the
macrophages affected the tumor cells differently dependent
upon whether they were M1 or M2. Initial work has indi-
cated a reduction in tumor cell viability in the presence of
M1 macrophages and the reverse in the presence of M2
macrophages. Additionally, morphological changes are evi-
dent dependent upon the macrophage presence. Ongoing
studies using patient-specific tumor cells and macrophages
seek to assess clinically relevant drug response.
Conclusions
With this 3D tetra-culture model system, we have investi-
gated macrophage differentiation, changes in tumor mor-
phology and survival, and drug response. The use of
readily available sources of differentiated macrophages in
the 3D co-culture model may assist with preclinical bio-
marker and novel immuno-oncology drug development,
while the matched tumor-macrophage models may serve
as personalized ex vivo cell-based immuno-oncology
assays used to guide clinical decision making.
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